Kyrgyzstan Medical Device Regulatory Calendar 2026-2028: Transition Deadlines and Action Plan

1. Key takeaways

Between 2026 and 2028, the density of regulatory change in Kyrgyzstan is high by the standards of this region. Five verified milestones stand out: the transitional protocol signed on December 29, 2025 → the protocol expanding the Union-level registration-exemption list signed on February 9, 2026 → Cabinet Resolution No. 450 of June 29, 2026 rebuilding the inspection procedure → the draft amendments to the registration procedure in progress during 2026 → the two transition endpoints of December 31, 2027 and December 31, 2028. This is not change that can be waited out; it is a round of adjustments that requires actions scheduled backward from each milestone.

2. Legal basis

1. Protocol amending the agreement of December 23, 2014, signed December 29, 2025: extends the national-track application deadline to December 31, 2027, and re-registration and changes to December 31, 2028; provisionally applied 10 days after signature.
2. Protocol expanding the Union-level registration-exemption list, signed February 9, 2026: adds four categories of registration-exempt situations.
3. Cabinet Resolution No. 450, June 29, 2026: approves the Procedure for Inspections in the Field of Medical Device Circulation, repeals item 1 of Government Decree No. 120 of March 15, 2019, enters into force 10 days after official publication, and instructs the Ministry of Health to take implementing measures within two months.
4. Draft amendments published for public consultation in 2026 by the Ministry of Health of the Kyrgyz Republic (to amend Cabinet Resolution No. 513): the simplified pathway for eight countries is to be shortened from 30 calendar days to 10 working days; an inspection report recognition mechanism based on confirmation by at least two member states is to be introduced; registration certificates are to be digitalized (draft status).
5. Cabinet resolution on the National List of Essential Medicines and Nationally Important Medical Devices for 2026–2028 (early October 2026).
6. Verified member state ratification progress: approved by the Chamber of Representatives of Belarus on June 3, 2026; approved by the Russian Federation through Federal Law No. 288-FZ of August 4, 2026.

3. Expert insights

Insight one: the two protocols address the two dimensions of time and scope.

The protocol of December 29, 2025 extends the transition period (the time dimension); the protocol of February 9, 2026 expands the registration-exemption list (the scope dimension). Both dimensions serve the same goal: relieving the load on the Union registration system. Understanding this makes it possible to anticipate the direction of travel — while system capacity remains insufficient, both deadlines and scope are still open to further adjustment.

Insight two: Cabinet Resolution No. 450 is a structural change at the national level.

Unlike the two protocols (Union level), Resolution No. 450 is a Kyrgyz national measure: it separates inspection out of the registration procedure and makes it an independent procedure. This tells companies that even if the Union-level transition is postponed again, institution-building at the national level continues to advance. Tracking this market means watching both lines.

Insight three: if the draft amendments land, they will change the structure of time costs.

The three elements of the draft — compressing the eight-country pathway to 10 working days, recognizing inspection reports confirmed by at least two member states, and digitalizing registration certificates — all point to reducing duplicated work. The direct implication for manufacturers from China is that whether you hold a recognized third-party approval or an inspection report from within the Union will determine the order of magnitude of your time costs.

Insight four: the action lists for the two transition endpoints differ.

• December 31, 2027: the last day to submit registration/appraisal applications under the national track. Action: complete submission of all new products intended for the national track.
• December 31, 2028: the last day to complete re-registration and dossier changes under the national track. Action: complete re-registration of the installed base and close out all known changes.

The full year between the two endpoints is the transformation period for existing products.

Insight five: the realistic window for Union-track preparation is shorter than the two years on paper.

The transition may appear to have been pushed back by two years, but the capacity of testing laboratories and expert organizations is limited. If most companies start the Union track in the second half of 2027, queue times will lengthen considerably. We recommend completing the technical preparation for the Union track before the first half of 2027 (see article 12 of this series).

4. Practical recommendations

First, build a two-level tracking mechanism. We recommend tracking the Union level (protocols, decisions of the Eurasian Economic Commission) and the national level (cabinet resolutions, ministry drafts) as two separate lines, each with an assigned owner.

Second, schedule actions backward from the milestones. We recommend converting the five milestones into a table of corresponding actions: milestone date, action, responsible department, completion criteria, and required lead time.

Third, front-load Union-track technical preparation into the first half of 2027. We recommend completing technical file preparation, testing arrangements and inspection coordination before the first half of 2027, avoiding the queue peak.

Fourth, run a consolidated review of legacy changes during 2027. We recommend completing a full dossier review of all products within 2027, consolidating four categories of needs — model extensions, site changes, replacement of the authorized representative, and label updates — into submissions closed out before December 31, 2028.

Fifth, build in flexibility for further deadline changes. The transition has already been postponed twice. We recommend building trigger-based clauses into commercial contracts and project plans, rather than writing migration by 2028 as an unadjustable hard constraint.

5. Verification checklist

• □ A two-level tracking mechanism is in place: Union level (protocols, decisions of the Eurasian Economic Commission) and national level (cabinet resolutions, ministry drafts);
• □ An action table scheduled backward from the five milestones is in place (December 29, 2025 / February 9, 2026 / June 29, 2026 / draft in progress / December 31, 2027 and December 31, 2028);
• □ Union-track technical preparation is scheduled for completion before the first half of 2027;
• □ The legacy dossier review is scheduled within 2027, with known changes closed out before December 31, 2028;
• □ Commercial contracts and project plans include flexible clauses for further deadline changes;
• □ The currently valid texts published by the Kyrgyz Republic have been obtained to verify the domestic ratification progress of the protocols.

Regulatory information verified as of October 29, 2026.

Our services cover pre-market pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, manufacturing site inspection coordination, quality management system conformity support, post-market surveillance and vigilance system setup, import and distribution compliance, and fee calculation and project budget management.

The GRZAN regulatory team consists of professionals with many years of hands-on experience in Eurasian Economic Union registrations and has built stable local cooperation networks in Bishkek, Almaty, Tashkent and Moscow. Working in Chinese, Russian and English, we deliver actionable solutions for foreign manufacturers on the key issues commonly encountered in CIS markets, including authorized representative arrangements, notarization and legalization chains for powers of attorney, localization of technical documentation, and inspection readiness.

We hold to one principle: every regulatory conclusion we publish must be traceable to verifiable official sources; figures and timelines that cannot be verified are always marked as practical estimates and are never presented as legal requirements drawn from experience.

GRZAN provides registration and compliance support in this country for manufacturers, importers and authorized representatives. For project inquiries on market access in Kyrgyzstan or the Eurasian Economic Union, please contact us at info@grzanglobal.com.

GRZAN | Global Regulatory Registration and Compliance Services for Medical Devices